The Bellcast

In this special edition of Bell Direct’s From the helm series, we take a closer look at LinQ Minerals – a company set to make waves with its upcoming IPO.

With investor interest in gold and copper ramping up, Bell Direct Market Analyst Grady Wulff speaks with Executive Chairman Clive Donner to discuss LinQ’s standout assets in NSW, recent high-grade drill results, and post-listing strategy.

In this video, Clive discusses:
• (0:30...

Join our Market Analyst, Grady Wulff as she sits down with Bell Potter's Analyst, John Hester as he discusses an update on the below healthcare stocks.

In this video, John discusses:
- (3:15) Telix's Pharmaceuticals (ASX:TLX)
- (7:34) Clarity Pharmaceuticals (ASX:CU6)
- (10:54) Avita Medical (ASX:AVH)
- (12:16) Mesoblast (ASX:MSB)
- (14:31) Promedicus (ASX:PME)

Note: This interview wa...

Join Market Analyst Grady Wulff as she sits down with Scott Kirkland, CEO and Managing Director of EMVision Medical Devices (ASX:EMV), to discuss how the company’s pioneering portable brain scanner is set to revolutionize stroke diagnosis and care.

In this video, Scott covers:

• (0:31) EMVision’s history and breakthrough technology
• (3:09) key trial results and development progress
• (8:54) US market oppo...

In this latest instalment of Bell Direct’s From the helm series, we kick off 2025 with an exciting deep dive into the healthcare sector. Host Bell Direct’s Market Analyst, Grady Wulff sits down with Opthea (ASX:OPT) CEO, Fred Guerard to discuss the company’s remarkable 168% share price surge over the past six months as it advances toward commercialising its novel retinal disease treatment, Sozinibercept. With an initial focus on we...

In today’s market update, we’re diving into the latest inflation numbers for Australia, with underlying inflation falling to its lowest level in 3 years at 3.2%, exceeding expectations and bringing it closer to the RBA’s target range. While CPI for the 12-months to December rose by 2.4%, we saw some sectors, like housing and transport, offsetting price increases in areas like recreation and alcohol. This decline in inflation raises...

Dive into the latest commodity trends with our Market Analyst Grady Wulff’s quarterly chat featuring Lion Selection Group (ASX:LSX) CEO, Hedley Widdup.

Gold’s 2024 Performance – What’s Next?
Gold dazzled in 2024, reaching record highs of US$2,697/oz. Can this momentum continue with Trump back in office? Hedley sees strong tailwinds ahead, fuelled by:

• inflation concerns and geopolitical uncertainty
• robust demand from China and...

Our Market Analyst, Grady Wulff, sits down over the next 6 minutes with 6 executives who are exploring all parts of the world from uranium to a gold and silver deposit discovered in Chile recently.

Watch Grady catch up with the following executives:

• (0:42) Neil McDonald, Managing Director - Gold Hydrogen
• (1:45) Rowan Johnston, Executive Chair - Kin Mining
• (2:28) Chris Byrne, Managing Director - Legacy Minerals
• (3:37) Siobh...

This audio was filmed by and belongs to the ASX.

Our Market Analyst, Grady Wulff, featured on the ASX The Ideas Exchange Podcast, hosted by Jacinta King. 

In this episode, Grady talks about: 

• Sector outlook 
• How far can the tech rally go? 
• Will gold remain popular in 2024? 
• Consumer Discretionary surprised the market in 2023
• Opportunities to assess in 2024.

Be sure to listen to the episode on the ASX website h...

In this instalment of our From the helm series, Bell Direct’s Grady Wulff speaks to DroneShield's (ASX:DRO) Managing Director and CEO, Oleg Vornik.

DroneShield is making waves in the capital goods industry through the use of artificial intelligence and machine learning. The company is an Australia defence manufacturer specialising in counter-drone technology, servicing military and intelligence, law enforcement, critical infras...

Live from the Resources Rising Stars conference on the Gold Coast, Bell Direct's Market Analyst, Grady Wulf, sat down with Liontown Resources (ASX:LTR) Chairman and mining magnate, Tim Goyder to discuss updates on the Kathleen lithium project, the Albemarle takeover and the company's outlook for the next 12 months. Hear it from the Helm here, as we collaborate with Resources Media to bring you the From the Helm Live at th...

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
- (0:34) Impacts of Ferring's FDA approval on Microba
- (5:30) Drivers behind Microba's increase in revenue
- (7:12) What 2023 looks like for Monash IVF
- (8:39) Monash IVF's rating
- (11:45)...

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara's journey, her approach to analysing a company, and the first stock to ...

In this instalment of our From the helm series, Bell Direct’s Grady Wulff speaks to Pilbara Mineral's (ASX:PLS) Managing Director & CEO, Dale Henderson.
 
Pilbara is making waves in the global lithium boom through its Pilgangoora Project, which is one of the largest independently owned hard rock lithium mines in the world.
 
In this video Dale discusses: 

• (0:32) The new partnership with Calix and what ...

In Part 2 of our Meet the Analyst series, Bell Direct's Grady Wulff sits down with Olivia Hagglund to talk about the stocks she covers in the technology sector: Ai Media (ASX:AIM) and Cluey (ASX:CLU).

In this video, Olivia discusses:

• (0:30) The reasoning behind the rating and price target of AIM
• (2:23) How AIM stays relevant post-pandemic
• (4:08) What AIM can do to overcome the risk of data breach
• (7:38) The rationale ...

View our brand new series: Meet the Analyst where Bell Direct's, Grady Wulff sits down and discusses stock recommendations with the analysts behind Bell Potter’s research.

Olivia Hagglund analyses stocks in the technology sector and discusses what’s important when valuing a company.

In this video, Olivia discusses:

• (0:29) Her background as an analyst
• (1:30) What approach she takes when analysing a stock
• (3:21) What she looks ou...

In this instalment of our From the helm series, Bell Direct’s Grady Wulff speaks to Starpharma's (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley.

 Starpharma Holdings Limited (ASX:SPL) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers. In this video Dr. Fairley discusses:

• (0:56) A brief overview of Starp...

In the most recent ASX-partnered ‘Ringing the Bell’ series, Tim Sparks talks to Roger Daniel, Senior Product Manager at the ASX.

As at the end of the June quarter, ETF assets listed on the ASX were above $121 billion across 275 products. Australian investors continue to embrace the ETF structure to gain access to markets and asset classes not previously available on the ASX.

In this video, Tim and Roger discuss:

• (1:00) Where ETF i...

As we enter into the new financial year, Sophia Mavridis caught up with SMSF expert Olivia Long.

They discuss a number of key changes to super that create opportunities for all SMSF members to grow their retirement savings. 

In this video Olivia covers:

• (0:28) Two key changes to super that are now in effect
• (2:36) The super guarantee contribution rate for FY23
• (3:37) The increased cut-off age to access the bring forward rule
• (4:45) C...